ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

Consecutive Day HSP90 Inhibitor Administration Improves Efficacy in Murine Models of KIT-Driven Malignancies and Canine Mast Cell Tumors.

Cheryl A London et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.